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ABSTRACT
Objective: The objective of this research was to formulate and evaluate olanzapine (OLE) mucoadhesive microsphere prepared using carbopol and 
sodium combination. OLE having extensive hepatic first pass metabolism and low bioavailability problem, determined the need for the development 
of sustained release formulation.
Methods: OLE mucoadhesive microspheres were prepared by ionic gelation method. OLE mucoadhesive microspheres were prepared by 
ionic gelation method by using calcium chloride as crosslinking agent. The OLE mucoadhesive microsphere was characterized by particle size 
measurement, process yield, morphology of microsphere, drug entrapment efficiency, mucoadhesion test, differential scanning calorimetry, powder 
X-ray diffraction, Fourier transforms infrared (FTIR) study and in-vitro drug release.
Results: The OLE mucoadhesive microsphere having mean particle size ranged from 546.0 µm to 554.3 µm, and the entrapment efficiencies ranged 
from 73% to 96%. All the olanzapine (OLE) microsphere batches showed good in-vitro mucoadhesive property ranging from 75.89% to 96.47% and 
in the in-vitro wash off test ranging from 68.12% to 81.3%. FTIR studies indicated the no drug-polymer interactions in the ideal formulation F9. There 
were no compatibility issues, and the crystallinity of OLE was found to be reduced shoeing less intense peak in prepared mucoadhesive microspheres, 
which were confirmed by differential scanning calorimeter and X-ray diffraction studies. Among different formulations, the OLE microspheres of 
batch F9 had shown the optimum percent drug entrapment of microspheres. Release pattern of OLE from F9 microspheres batch followed Higuchi 
kinetic model. Stability studies were carried out for F9 formulation at 4°C/ambient, 25±2°C/60±5%, 40±2°C/75±5% relative humidity revealed that 
the drug entrapment, mucoadhesive behavior, and drug release were within permissible limits.
Conclusion: The results obtained in this work demonstrate the use of carbopol and sodium alginate polymer for preparation of mucoadhesive 
microsphere.
Keywords: Ionic gelation method, Gastroretentive delivery, Mucoadhesive microsphere, Carbopol.
INTRODUCTION
Oral controlled drug delivery system such as mucoadhesive 
microsphere drug delivery systems used to prolong the residence 
time at the site of application or absorption. Microsphere is useful to 
maintain therapeutically effective plasma drug concentration levels 
for a longer duration there by reducing the dosing frequency and to 
minimize fluctuations in the plasma drug concentration at the steady 
state by delivering the drug in a controlled and reproducible manner. 
Mucoadhesive microspheres become adhesive on hydration and 
hence can be used for localizing the drugs to a particular target site 
of gastrointestinal tract (GIT) for prolong periods of time. Moreover, 
it is easy for administration, no patient compliances, and flexibility in 
the formulation. Mucoadhesive microspheres have advantages such as 
efficient absorption, enhanced bioavailability of the drugs, maximum 
utilization of drugs, much more intimate contact with intestinal cells, 
better patience compliance, and targeting to specific absorption 
site [1-3].
OLE is an atypical antipsychotic thienobenzodiazepine derivative 
used in the treatment of schizophrenia and bipolar 1 disorder. OLE is 
poorly soluble in water belongs to BCS class II and having only 60% 
oral bioavailability. OLE undergoes extensive first pass metabolism. 
In this regard, our main focus of this research is to prepare sustain 
microspheres of OLE which provides slow release in GIT and also 
assures the presence of dosage form at the site of absorption. OLE has 
been shown to selectively bind to central dopamine D2 and serotonin 
(5-HT2c3 receptors and is effective against the negative symptoms of 
schizophrenia with a lower incidence of extrapyramidal symptoms. 
A second generation atypical antipsychotic having moderate elimination 
half-life implying that once daily therapy is adequate for treatment of 
schizophrenic conditions [4-6].
Therefore, a drug delivery such as “mucoadhesive microsphere,” has 
been applied. Hence, the objective of this work was to formulate the 
mucoadhesive microsphere of OLE to improve residence of dosage 
form in GIT, reduced dosing frequency and enhance bioavailability in 
the treatment of schizophrenia.
MATERIALS AND METHODS
Materials
OLE was obtained from Enaltec Lab Private Ltd, Mumbai, India. Sodium 
alginate gift sample from Loba Chemical Mumbai, carbopol from 
Colorcon Asia Pvt. Ltd., Goa, and calcium chloride was purchased from 
S.B. Fine chemicals Ltd, Mumbai.
Preparation of microsphere
Ionic gelation method
The microspheres were prepared by ionotropic external gelation 
technique. The carbopol and alginate solution was prepared by 
initially dispersing the carbopol (2-6%) and sodium alginate (3% w/v) 
in deionized water employing mild heat (50°C) with by magnetic 
stirring. To this dispersion, OLE (200 mg) was added and sonicated for 
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30 minutes. The dispersion was then added dropsies from 20-gauge 
hypodermic needle fitted with a 10 ml syringe to solution of calcium 
chloride (5-10% w/v) stirred at 500 rpm. The gelled droplets were 
allowed to remain in calcium chloride solution for 30 minutes for 
complete curing, filtered, and washed repeatedly with deionized 
water to remove excess of CaCl2 that might have deposited on surface 
of microspheres. The microspheres were then dried at 50°C under 
vacuum [3,7].
Experimental design
The formula optimization was done by 32 factorial design using design 
expert (Version 9.2; Stat-Ease Inc., Minneapolis, Minnesota, USA) for 
mathematical modeling and analysis of responses. The optimal level of 
variables was determined by 32 factorial design including center point. 
The significant factors selected were concentration of carbopol and 
cross-linker concentration examining 9 runs.
Variables for experimental designs
Independent variable
X1 = concentration of polymer
X2 = cross-linking agent
Dependent variable
Y1 = Particle size
Y2 = Entrapment efficiency
Y3 = t% release
Particle size measurement
The size of the prepared microcapsules was measured by the optical 
microscopy method using a calibrated stage micrometer. Particle size 
was calculated using equation, Xg = 10 × ([ni × log Xi]/N), Where, Xg is 
geometric mean diameter, ni is number of particle in range, Xi is the 
midpoint of range and N is the total number of particles [8].
Factorial design
A 3² full factorial design was constructed using design expert for 
mathematical modeling and analysis of responses where the amounts 
of polymer (X1) and speed (X2) were selected as the independent factors. 
The levels of the two factors were selected and on the basis of the 
preliminary studies carried out before implementing the experimental 
design. A statistical model was used to evaluate the responses which 
involve polynomial terms.
Y = b0 + b1X1 + b2X2 + b12X1X2 + b11X1 + b22 X22
Where Y is the dependent variable, b0 is the arithmetic mean response 
of the 9 runs, and b1 is the estimated coefficient for the factor X1. The 
main effects (X1 and X2) represent the average result of changing one 
factor at a time and (X1 X2) represent interaction factor [9].
Process yield
Dried microspheres were accurately weighed, and considering 
the total amount of drug and polymers used for preparing the 
feed solution, the process yield was calculated, a using following 
formula [10].
Entrapment efficiency=






The external and internal morphology of the microspheres were 
studied using scanning electron microscopy in Pune University (Physics 
Department). The sample was loaded on copper sample holder and 
sputter coated with platinum [11].
Drug entrapment efficiency
Microspheres (50 mg) were powdered and suspended in 50 ml of 
0.1 N HCl followed by 30 minutes sonication. The solution was kept 
undisturbed for 24 hrs; and filtered. The filtrate recovered was 
examined spectrophotometrically at 227 nm, and entrapment efficiency 
was calculated by the following formula [12].
In-vitro wash off test for microspheres
The in-vitro wash off test was carried out to evaluate the mucoadhesive 
potential of the microspheres. In brief, a 1 cm by 1 cm rat mucosa was 
cut and tied onto glass slide by thread. Around 100 microspheres were 
spread on the wet mucosa, and the prepared slide was hung onto one 
of the grooves of the USP tablet disintegrating test apparatus filled with 
0.1 N HCl giving regular up and down movements for 60 minutes. At 
the end of 60 minutes, numbers of microspheres still adhering to the 
intestinal mucosa were counted [13].
In-vitro dissolution
The release rate of OLE from OLE microspheres was determined using 
USP Type II (paddle) dissolution test apparatus. The dissolution test was 
performed using 900 ml of dissolution medium of 0.1 N hydrochloric 
acids, at 37±0.5°C and a rotation speed of 50 rpm. In specified time 
intervals, an aliquot of 5 ml samples of the solution were withdrawn 
from the dissolution apparatus and with replacement of fresh fluid to 
dissolution medium. The samples were filtered through filter paper of 
0.45 μm. The samples were analyzed at 246 nm for drug content using 
ultraviolet spectrophotometer. The OLE release experiment was carried 
out [14].
Release kinetic studies
The rate and the mechanism of release of OLE from the prepared 
mucoadhesive microspheres were analyzed by fitting the dissolution 
data into various kinetic models such as zero order; first order, Higuchi’s 
model, and coefficient of correlation (r) values were calculated for the 
linear curves by regression analysis of the above plots [9].
Fourier transforms infrared spectroscopy (FTIR) studies
Infrared spectra for pure OLE and for the physical mixture of OLE and 
polymer was determined to check the intactness of the drug in the 
Table 1: 32 full factorial design layout, experimental runs and 
their combinations
S. N Batch No X1 X2
1 F1 −1 −1
2 F2 −1 0
3 F3 −1 1
4 F4 0 −1
5 F5 0 0
6 F6 0 1
7 F7 1 −1
8 F8 1 0
9 F9 1 1
Table 2: Formula and composition with process variables
Ingredient Formulation code
F1 F2 F3 F4 F5 F6 F7 F8 F9
Drug (olanzapine mg) 200 200 200 200 200 200 200 200 200
Polymer (carbopol and sodium alginate) g 4 5 6 4 5 6 4 5 6
Cross-linking agent g 1 1 1 1.5 1.5 1.5 2 2 2
Distilled water 100 100 100 100 100 100 100 100 100
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polymer mixture using FTIR - spectrophotometer. The samples were 
analyzed between wave numbers 4000 and 400/cm resolution [15].
Differential scanning calorimeter (DSC) studies
The thermal behavior of pure OLE and OLE microspheres were studied 
using a DSC Perkin Elmer DSC at a heating rate of 10°C/minutes. 
Samples were accurately weighed into aluminum pans and then sealed. 
The measurements were performed at a heating range of 25-300°C 
under nitrogen atmospheres [16,17].
X-ray diffraction study
X-ray diffractogram of the OLE and OLE-loaded microspheres were 
recorded by a diffractogram (Brucker AXS D8) using Cu line as a source of 
radiation which was operated at the voltage 40 KV and the current 40 mA. 
All samples were measured in the 2θ angle range between 5° and 60° [11].
Stability study
Stability studies were carried out for OLE microsphere as per ICH 
guidelines. The best mucoadhesive microspheres formulation (F9) 
was sealed in high-density polyethylene bottles and stored at 
25±2°C/60±5%, 40±2°C/75±5% relative humidity (RH) for 90 days. 
The samples (F9) were evaluated for entrapment efficiency and 
percentage mucoadhesion [18].
RESULT AND DISCUSSION
The OLE microsphere was prepared by orifice ionic gelation method. 
The formula optimization was done by 32 factorial design. The 
significant factors selected were concentration of sodium alginate and 
cross-linking agent. The dependant variables selected were entrapment 
efficiency, % mucoadhesion, and % drug release. Two factors affecting 
the experimental responses and three factors were selected as 
independent variables at three  levels (−1, 0 ,+1) as shown in (Table 1). 
Polynomial equations for individual response reflect the relationship 
between dependent and independent factors The model was analyzed 
for fitting into appropriate mathematical model and evaluated 
statistically for analysis of variance. The response surface analysis was 
carried out employing the 3D response surfaces.
Percentage yield
The percentage yield of microspheres was calculated using the weight 
of final product after drying with respect to initial total weight. The 
maximum percentage yield was found of F9 batch and was noted to be 
96.12% among all the batches. The production yields of microspheres 
prepared by ionotropic gelation method were found to be between 
73% and 96% as shown in Table 3.
Particle size
The average particle size of OLE microspheres ranged from 546.0 µm 
to 554.3 µm. The mean particle size was significantly increased with 
increasing mucoadhesive polymer concentration this may be attributed 
to high viscosity of mucoadhesive polymer concentration (Table 3).
Morphology of microspheres
The morphology of the mucoadhesive microspheres of best formulation 
F9 was examined by scanning electron microscopy (SEM). The SEM 
photographs revealed that ritonavir microspheres were discrete and 
irregular shape with a rough surface morphology (Fig. 1).
Entrapment efficiency
The maximum percentage yield was found of F9 batch and was 
noted to be 96.12% among all the batches. This may be attributed to 
increase in concentration of the sodium alginate polymer increased the 
entrapment efficiency of the microspheres due to the formation of more 
intact matrix network.
In-vitro wash off test for microsphere
To assess the mucoadhesive property of OLE mucoadhesive 
microspheres, in-vitro wash off test was carried out for all batches, 
and the results are shown in Table 4. The study of in-vitro wash 
off test revealed that all the batches of prepared microspheres had 
good mucoadhesive property ranging from 68.12% to 81.3%. This 
may be attributed that on increasing the polymer concentration, the 
mucoadhesive property of the microspheres also increased (Fig. 3).
In-vitro drug release studies
The in-vitro drug release studies were carried out for all batches 
of microspheres shown in Fig. 4. Drug release from these 
mucoadhesive microspheres were slow, controlled release, and 
dependent on the nature and concentration of polymers used. 
Among all the formulations F9 showed good dissolution profile 
with 75.89%. It was found that drug release rate decreased as 
the concentration of polymer increased and also with increased 
concentration of cross-linking. Hence, it is considered as the best 
microsphere formulation, which seems to be a good candidate for 
controlled release of OLE.
Release kinetic study
The in-vitro drug release data were fitted into various mathematical 
models. The model that best fits the release data were evaluated by 
correlation coefficient (r). The correlation coefficient (r) value was 
used to choose the best model to describe the drug release from the 
microsphere. As the regression coefficient (r2) value of the Higuchi 
model was found to be higher. The r value in various models is given 
in Table 5. All the microsphere formulations (F1-F9) followed Higuchi 
model with regression values ranging from 0.9439 to 0.9971.
FTIR studies
FTIR spectrum of pure drug and mucoadhesive microsphere of drug 
and polymers were studied (Fig. 5). It was observed that OLE showed 
Table 3: Percentage yield, particle size, percentage mucoadhesion, in-vitro release ((%)±S.D (n=3)) data of all batches
Formulation code X1 X2 Percentage yield Particle size Percentage mucoadhesion In-vitro release
F1 −1 −1 73.11±1.5 546±3.46 68.12±0.75 96.47±0.16
F2 −1 0 78.34±1.02 548.2±2.68 72.39±1.11 90.2±0.36
F3 −1 1 86.04±1.12 547.1±2.19 80.12±1.66 87.35±0.26
F4 0 −1 78.29±1.46 549.3±3.65 71.1±1.26 88.37±0.36
F5 0 0 83.14±2.46 550.4±1.54 79±1.46 82.58±0.41
F6 0 1 91.1±2.19 551.1±3.89 85±1.06 78.19±0.04
F7 1 −1 82.15±1.96 552.1±1.36 75.5±0.96 80.17±0.36
F8 1 0 89.1±2.01 553.2±1.27 81.3±1.46 78.64±0.29
F9 1 1 96.12±1.56 554.3±1.94 80.31±1.56 75.89±0.26
X1: Concentration of polymer. Each sample was analyzed in triplicate (n=3) (%)±S.D (n=3), X2: Cross-linking agent, SD: Standard deviation
Fig. 1: Scanning electron photomicrographs of the formulation F9, 
(a) ×35, (b) ×500 factorial equation
a b
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characteristic peak at 3337/cm for – NH group whereas sodium 
alginate showed – CO group at 1670/cm, – OH group at 3100/cm and –
NH group at 3563/cm. While carbopol showed –CO group at 1653/cm 
however shift in – CO group peak of polymer (alginate) and – NH group 
of OLE to 1696/cm and 3563/cm suggested possibility of H-bonding 
between drug and polymer. DSC thermogram also showed shift in 
melting point of drug and no interaction between drug and polymer 
(Fig. 5 and 6).
DSC studies
The thermal behavior of prepared OLE microspheres was studied in 
comparison with thermograms of pure OLE as shown in (Fig. 7) The 
thermogram of pure OLE showed a sharp endothermic peak at 195°C 
whereas formulation containing OLE showed 2 melting endotherm 
Fig. 2: Drug content 3 D graph
Fig. 3: Percent mucoadhesion 3 D graph
Fig. 4: Percent drug release 3 D graph









F1 0.9012 0.8932 0.9439
F2 0.9397 0.9611 0.9771
F3 0.9752 0.9673 0.9841
F4 0.9195 0.9521 0.9512
F5 0.9443 0.9613 0.9623
F6 0.9517 0.9532 0.9701
F7 0.9639 0.9194 0.9754
F8 0.9532 0.9641 0.9663
F9 0.9878 0.9853 0.9971
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at 126.95°C and 190.14°C which correspond to melting platinum of 
polymer and drug indicating that there is no interaction between drug 
and polymer as shown in Figs. 7 and 8.
Powder X-ray diffraction study
The X-ray diffractogram of OLE showed sharp peaks depicting a typical 
crystalline pattern. Physical mixtures showed less intense peaks, 
Fig. 6: Fourier transforms infrared of olanzapine microsphere
Fig. 7: Differential scanning calorimeter thermogram of olanzapine
Fig. 5: Fourier transforms infrared of pure olanzapine
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changed to amorphous form. This diminished peak suggests conversion 
of drug into amorphous form as shown in Figs. 9 and 10.
Stability studies
Stability studies for the optimized microsphere were carried out at a 
temperature of 40±2°C/RH 75±5% for a period of 90 days. Formulation 
was evaluated for physical appearance and drug content. There was no 
any significant change in physical appearance and drug content during 
stability studies. Hence, it was concluded that the F9 batch of tablet has 
good stability during their shelf life.
Factorial equation
All the polynomial equations were found to be statistically significant 
determined using as per provision of design expert software. The 
equation can draw conclusion after considering magnitude of coefficient 
and mathematical sign carried.
Factorial equation for drug content
% drug content = 26.77407 + 0.59637 X1 −5.2666 X2 −2.9333 X1 
X2 −6.7851 X12 + 0.43733 X22 (1)
Where, X1 = concentration of polymer and X2 = cross-linking agent
Drug entrapment efficiency was found to be 61.83-70.12% (Table 3). It 
was found that increasing sodium alginate concentration was found to 
increase in content efficiency and as the concentration of cross-linking 
agent decreases drug content increased. Correlation coefficient was 
found to be 0.9976. The surface response showing effect of variables on 
drug entrapment efficiency is shown in Fig. 2.
Factorial equation for % mucoadhesion
% mucoadhesion = −5.70370 + 0.1674 X1 −2.0000 X2 −3.8072 X1 
X2 −1.48148 X12  0.2666 X22 (2)
Where, X1 = concentration of polymer and X2 = cross-linking agent
Factorial equation concerning mucoadhesion showed that the 
coefficients bear a positive sign. Hence, increasing the amount of 
the polymer in the formulations increased the mucoadhesion. The 
percentage mucoadhesion varied from 68.12% to 85.00% (Table 4) and 
showed a good correlation coefficient (0.9922). Thus, we can conclude 
that the amount of sodium alginate directly affects the percentage of 
mucoadhesion.
Factorial equation for % drug release
% drug release = 125.334 −0.2334 X1 + 0.6966 X2 −5.2666 X2+ 0.02020 
X1 X2 −1.6518 X12 −0.6667 X22 (3)
Where X1 = concentration of polymer and X2 = cross-linking agent
Factorial equation concerning drug release showed coefficient of 
variable X1 was found to be negative (−3.93) which indicate that release 
of drug from microsphere was inversely proportional to amount of 
polymer(sodium alginate and carbopol) and cross-linking agent, 
i.e., calcium chloride. The % drug release is observed to increase with 
decreased concentration of carbopol. The percentage drug release 
varied from 75.89% to 96.47% (Table 4) and showed a good correlation 
coefficient (0.9842).
CONCLUSION
This study has been attempted to formulate a mucoadhesive 
microsphere of OLE for oral administration for increasing bioavailability 
of the drug. The results of 3² full factorial design revealed that the 
concentration of sodium alginate significantly affected the dependent 
variables percentage mucoadhesion, drug entrapment efficiency, and 
drug release property. Microsphere formulation of OLE was prepared 
using ionic gelation method using sodium alginate as polymer and 
calcium chloride as a cross-linking agent.
Fig. 8: Differential scanning calorimeter thermogram of 
olanzapine microsphere
Fig. 9: Powder X-ray diffraction of olanzapine microsphere
Fig. 10: Powder X-ray diffraction of olanzapine pure drug










F9 R2 value 0.9976 0.9922 0.9842
however, OLE-loaded mucoadhesive microspheres showed less intense 
peaks, however, OLE-loaded mucoadhesive microspheres showed 
peaks, but of low intensity, revealing that some amount of OLE was 
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From the results, it can be concluded that the IR and DSC spectra 
revealed that there was no interaction between polymer and drug OLE. 
The particle size analysis revealed that all formulations having particles 
in the range of 546.0-553.3 µm. Among all the formulation F9 was 
selected as best formulation which showed the good entrapment 
efficiency (96.12%), good mucoadhesion in 8 hrs (80.31%) and good 
drug release profile (75.89%). In-vitro drug release data followed 
Higuchi model with regression values ranging from 0.9439 to 0.9971. 
SEM analysis of the F9 microspheres revealed that the formulation was 
spherical and rough surface morphology. The prepared mucoadhesive 
microspheres of OLE showed sustained release action with increased 
therapeutic efficacy and increased patient compliance.
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